TAMMY MORGAN: Open Payments
NPI 1992336614 · BEE CAVES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 84 payments from 16 companies in 2025. Trend: 2023 $1,390 · 2024 $1,550 · 2025 $1,760
Food & beverage: $1,630Education: $130
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $400 |
| AstraZeneca Pharmaceuticals LP | 9 | $218 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $217 |
| GlaxoSmithKline, LLC. | 12 | $167 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| CSL Behring | 3 | $93 |
| GENZYME CORPORATION | 3 | $62 |
| Organon LLC | 2 | $60 |
| PFIZER INC. | 3 | $59 |
Products named: DUPIXENT, NEFFY, FASENRA, TRELEGY ELLIPTA, XOLAIR, TEZSPIRE, Hizentra, PANZYGA.
Industry payments across TX — which companies pay providers there.
